TP53 and colorectal carcinoma: Here we demonstrate that a common version of this complexity linked to aggressive CRC disease—combining alterations in RAS, APC, and P53—is sufficient to direct overgrowth of the hindgut proliferative zone (HPZ) and promote emergent drug resistance.